WPRIM Management System> DCMS> Kidney Research and Clinical Practice> 2017> 36

Volume: 36

1. Unilateral renal atrophy associated with abdominal aortic aneurysm. Page:394—395
2. Type 1 primary hyperoxaluria in a male infant. Page:393—393
3. Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy. Page:387—392
4. Changes in geriatric nutritional risk index and risk of major adverse cardiac and cerebrovascular events in incident peritoneal dialysis patients. Page:377—386
5. Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data. Page:368—376
6. Prognostic performance of combined use of high-sensitivity troponin T and creatine kinase MB isoenzyme in high cardiovascular risk patients with end-stage renal disease. Page:358—367
7. Physician perceptions of blood pressure control in patients with chronic kidney disease and target blood pressure achievement rate. Page:349—357
8. Cockcroft-Gault, Modification of Diet in Renal Disease, and Chronic Kidney Disease Epidemiology Collaboration equations for estimating glomerular filtration rates in cancer patients receiving cisplatin-based chemotherapy. Page:342—348
9. Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy. Page:200—204
10. Clinical analysis of single filtration plasmapheresis using continuous renal replacement therapy machines in kidney transplantation. Page:192—199
11. Relationship between trajectories of serum albumin levels and technique failure according to diabetic status in peritoneal dialysis patients: A joint modeling approach. Page:182—191
12. The feasibility of surgical salvage of thrombosed arteriovenous fistula by an interventional nephrologist. Page:175—181
13. The effect of the physical activity on polymorphic premature ventricular complexes in chronic kidney disease. Page:167—174
14. Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial. Page:159—166
15. A unified pathogenesis for kidney diseases, including genetic diseases and cancers, by the protein-homeostasis-system hypothesis. Page:132—144
16. Renal sodium handling and sodium sensitivity. Page:117—131
17. Middle East respiratory syndrome clinical practice guideline for hemodialysis facilities. Page:111—116
18. Anti-inflammatory and anti-apoptotic effects of paricalcitol in lipopolysaccharide-induced renal proximal tubular cell injury. Page:109—110
19. A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival. Page:22—28
20. The role of renal proximal tubule transport in the regulation of blood pressure. Page:12—21
21. Medical big data: promise and challenges. Page:3—11
22. Kidney disease and obesity paradox. Page:1—2
23. Active maintenance of endothelial cells prevents kidney fibrosis. Page:329—341
24. Maturation of arteriovenous fistula: Analysis of key factors. Page:318—328
25. Renal intercalated cells and blood pressure regulation. Page:305—317
26. Serum uric acid and mortality risk among maintenance hemodialysis patients. Page:302—304
27. Active maintenance of endothelial cells prevents kidney fibrosis. Page:329—341
28. Epoxyeicosatrienoic acid activation moderates endothelial mesenchymal transition to reduce obstructive nephropathy. Page:299—301
29. Maturation of arteriovenous fistula: Analysis of key factors. Page:318—328
30. Renal intercalated cells and blood pressure regulation. Page:305—317
31. Serum uric acid and mortality risk among maintenance hemodialysis patients. Page:302—304
32. Epoxyeicosatrienoic acid activation moderates endothelial mesenchymal transition to reduce obstructive nephropathy. Page:299—301
33. Azathioprine treatment in two children with Henoch–Schönlein purpura nephritis. Page:205—206
34. Paricalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E₂ receptor EP4. Page:145—158
35. Staphylococcal infection-associated crescentic immunoglobulin A nephropathy. Page:296—297
36. Numerical expression of volume status using the bioimpedance ratio in continuous ambulatory peritoneal dialysis patients: A pilot study. Page:290—295
37. Association of serum uric acid level with coronary artery stenosis severity in Korean end-stage renal disease patients. Page:282—289
38. Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis. Page:274—281
39. The effects of different physical activities on atrial fibrillation in patients with hypertension and chronic kidney disease. Page:264—273
40. Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome. Page:257—263
41. Heart rate is associated with mortality in patients undergoing continuous renal replacement therapy. Page:250—256
42. The influence of hypophosphatemia on outcomes of low- and high-intensity continuous renal replacement therapy in critically ill patients with acute kidney injury. Page:240—249
43. Red cell distribution width predicts incident dipstick albuminuria in Korean adults without chronic kidney disease. Page:232—239
44. A calpain inhibitor protects against fractalkine production in lipopolysaccharide-treated endothelial cells. Page:224—231
45. Treatment of renal anemia: Erythropoiesis stimulating agents and beyond. Page:209—223
46. The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol. Page:207—208
47. The authors' reply: Letter to the Editor: Cardiac arrest caused by nafamostat mesilate: Kounis syndrome in the dialysis room?. Page:107—107
48. Letter to the Editor: Cardiac arrest caused by nafamostat mesilate: Kounis syndrome in the dialysis room?. Page:105—106
49. Syndrome of inappropriate antidiuretic hormone secretion associated with seronegative neuromyelitis optica spectrum disorder. Page:100—104
50. HELLP syndrome in a pregnant patient with Gitelman syndrome. Page:95—99
51. Neuro-tracing approach to study kidney innervation: a technical note. Page:86—94
52. Clinical experience with ultrasound guided angioplasty for vascular access. Page:79—85
53. Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea. Page:68—78
54. Resistive index as a predictor of renal progression in patients with moderate renal dysfunction regardless of angiotensin converting enzyme inhibitor or angiotensin receptor antagonist medication. Page:58—67
55. Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study. Page:48—57
56. Body mass index is inversely associated with mortality in patients with acute kidney injury undergoing continuous renal replacement therapy. Page:39—47
57. A computer-aided diagnostic system for kidney disease. Page:29—38